| RS2145004096 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2145004155 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS2145008460 |
PTBP1
|
Health Risk |
Pathogenic |
PTBP1-related neurodevelopmental disorder with skeletal dysplasia, STAD SYNDROME |
| RS2145009900 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2145009956 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS2145010299 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2145010446 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2145011418 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145011788 |
LAMA3
|
Health Risk |
Likely pathogenic |
— |
| RS2145011802 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2145012002 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2145012125 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2145012275 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2145013673 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
STAT3-related disorder, STAT3-related disorder |
| RS2145014205 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2145024323 |
DCC
|
Health Risk |
Pathogenic |
Mirror movements 1, Mirror movements 1 |
| RS2145027657 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145028011 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145029870 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145030202 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145030551 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145030587 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
CACNA1A-related complex neurodevelopmental disorder, Episodic ataxia type 2 |
| RS2145030772 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2145031089 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145032405 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145032534 |
AMH
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2145032993 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145033356 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145036791 |
LRFN1
|
Health Risk |
Likely pathogenic |
LRFN1, LRFN1 |
| RS2145043248 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS2145048234 |
TXNL4A
|
Health Risk |
Pathogenic |
Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome, Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome |
| RS2145048688 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2145048931 |
CLPP
|
Health Risk |
Likely pathogenic |
Perrault syndrome 3, Perrault syndrome 3 |
| RS2145049426 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2145050572 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2145051196 |
CLPP
|
Health Risk |
Pathogenic |
— |
| RS2145051267 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Global developmental delay |
| RS2145054624 |
DCC
|
Health Risk |
Likely pathogenic |
— |
| RS2145055524 |
LAMA3
|
Health Risk |
Likely pathogenic |
— |
| RS2145057679 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency 1, MHC class II deficiency 1 |
| RS2145059680 |
CIITA
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2145063212 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145074473 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145076139 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145078770 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145079010 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145080530 |
MAP2K2
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 4, Cardiofaciocutaneous syndrome 4 |
| RS2145081656 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145081748 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145085082 |
THRA
|
Health Risk |
Likely pathogenic |
Congenital nongoitrous hypothyroidism 6, Congenital nongoitrous hypothyroidism 6 |
| RS2145085179 |
THRA
|
Health Risk |
Pathogenic |
— |
| RS2145087228 |
THRA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2145087272 |
THRA
|
Health Risk |
Pathogenic |
— |
| RS2145087630 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2145087756 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2145089035 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2145089648 |
TXNL4A
|
Health Risk |
Pathogenic |
Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome, Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome |
| RS2145091141 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145091349 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2145092336 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2145092472 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2145092503 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2145092515 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145093044 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2145094562 |
SETBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2145094630 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145094895 |
BRIP1
|
Health Risk |
Pathogenic |
— |
| RS2145095402 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schinzel-Giedion syndrome, Intellectual disability |
| RS2145095898 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145095957 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145097019 |
COG1
|
Health Risk |
Pathogenic |
COG1 congenital disorder of glycosylation, COG1 congenital disorder of glycosylation |
| RS2145097039 |
THRA
|
Health Risk |
Pathogenic |
Congenital nongoitrous hypothyroidism 6, Congenital nongoitrous hypothyroidism 6 |
| RS2145097123 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS2145098103 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145098172 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145099229 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2145100544 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2145100763 |
PGAP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS2145104146 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schinzel-Giedion syndrome, Intellectual disability |
| RS2145104416 |
TERB1
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Spermatogenic failure 60 |
| RS2145104445 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS2145105037 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS2145105580 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schinzel-Giedion syndrome, Intellectual disability |
| RS2145105600 |
SETBP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2145106470 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS2145106713 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145107064 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145108345 |
SETBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2145108363 |
SETBP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2145110485 |
SETBP1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2145114772 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2145114867 |
SETBP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2145114965 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2145120326 |
CREB3L3
|
Health Risk |
Pathogenic |
Hypertriglyceridemia 2, Hypertriglyceridemia 2 |
| RS2145124301 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145124774 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145125519 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145134667 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145135618 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145135739 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |